- Neuropeptides and Animal Physiology
- Lung Cancer Research Studies
- Neuroendocrine Tumor Research Advances
- Liver physiology and pathology
- Hepatocellular Carcinoma Treatment and Prognosis
Georgetown University
2020
Hepatocellular carcinoma (HCC) is the fastest growing cancer worldwide in part due to obesity epidemic and fatty liver disease, particularly nonalcoholic steatohepatitis (NASH). Chronic inflammation with release of cytokines chemokines activation hepatic stellate cells results changes extracellular matrix (ECM) that predisposes development HCC. Blood levels gastrointestinal peptide cholecystokinin (CCK) are increased humans mice consuming a high-fat diet. We found CCK-B receptor (CCK-BR)...
<p>Supplemental Table S1 and Supplemental Figures S1-S3</p>
<p>Supplemental Table S1 and Supplemental Figures S1-S3</p>
<div>Abstract<p>Hepatocellular carcinoma (HCC) is the fastest growing cancer worldwide in part due to obesity epidemic and fatty liver disease, particularly nonalcoholic steatohepatitis (NASH). Chronic inflammation with release of cytokines chemokines activation hepatic stellate cells results changes extracellular matrix (ECM) that predisposes development HCC. Blood levels gastrointestinal peptide cholecystokinin (CCK) are increased humans mice consuming a high-fat diet. We found...
<div>Abstract<p>Hepatocellular carcinoma (HCC) is the fastest growing cancer worldwide in part due to obesity epidemic and fatty liver disease, particularly nonalcoholic steatohepatitis (NASH). Chronic inflammation with release of cytokines chemokines activation hepatic stellate cells results changes extracellular matrix (ECM) that predisposes development HCC. Blood levels gastrointestinal peptide cholecystokinin (CCK) are increased humans mice consuming a high-fat diet. We found...